ESOMEPRAZOLE MAGNESIUM; NAPROXEN | A204206 | DR REDDYS LABORATORIES LTD
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition From Horizon Pharma, Inc. FDA-2014-P-0209 · 3 docket documents Horizon Pharma, Inc. filed this citizen petition on February 3, 2014, requesting that the FDA require any Abbreviated New Drug Application for a generic version of VIMOVO (naproxen/esomeprazole magnesium) that does not completely enterically coat the naproxen component to be supported by either equ | 505(q) | 2014-03-07 | Denied | Horizon Pharma, Inc. |
Source: Regulations.gov. FDA citizen petitions matched by application number.
Highest NADAC/Unit
$2.82
per ea
Lowest NADAC/Unit
$2.47
per ea
Brand NDCs
0
Generic NDCs
2
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 55111028960NAPROXEN-ESOMEPRAZ DR 375-20 MG | $2.82 | EA | Generic | — | 2026-06-17 |
| 55111070160NAPROXEN-ESOMEPRAZ DR 500-20 MG | $2.47 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.